Viewing data from:

METOLAZONE

ANDA

METOLAZONE | A214799 | UNICHEM LABORATORIES LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.3886

per ea

Lowest NADAC/Unit

$0.2234

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
76385013801METOLAZONE 10 MG TABLET	$0.3886	EA	Generic	—	2026-06-17
76385013701METOLAZONE 5 MG TABLET	$0.2945	EA	Generic	—	2026-06-17
76385013601METOLAZONE 2.5 MG TABLET	$0.2234	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED EVIONNAZ SAMETOLAZONE

DMF 57481985

CURIA NEW YORK INCMETOLAZONE, USP

DMF 119581996

CENTAUR PHARMACEUTICALS PRIVATE LTDMETOLAZONE USP

DMF 303102016

BIOPHORE INDIA PHARMACEUTICALS PVT LTDMETOLAZONE USP

DMF 328682018

MSN LIFE SCIENCES PRIVATE LTDMETOLAZONE USP

DMF 336982019

EASTMAN KODAK COInactiveMETOLAZONE (ZAROXOLYN)

DMF 46551982

SUMIKA FINE CHEMICALS CO LTDInactiveMETOLAZONE

DMF 64381986

HEXAGON LABORATORIES INCInactiveMETOLAZONE

DMF 64871986

DIOSYNTH BVInactiveMETOLAZONE

DMF 75291988

HOECHST MARION ROUSSEL SAInactiveMETOLAZONE

DMF 84211990

XIAN LIBANG PHARMACEUTICAL CO LTDInactiveMETOLAZONE USP

DMF 160012002

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 30, 2021

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 30, 2021

#003 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 30, 2021